UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 29, 2026 4:00 P.M.
Form:
S-1
CIK:
0002075320
Company Name:
Polaryx Therapeutics, Inc.
File Number:
333-291681